Buscar
Mostrando ítems 21-30 de 124
Differential Sars-cov-2 antigen specificity of the humoral response inactivated virus-vaccinated, convalescent, and breakthrough subjects
(2022)
Analytical methods for the differential determination between natural infection with SARS- CoV-2 vs. immunity elicited by vaccination or infection after immunization (breakthrough cases) represent attractive new research ...
Immune Thrombocytopenic Purpura following CoronaVac vaccination: a case report
(HCPA/FAMED/UFRGS, 2023)
SARS-CoV-2 Neutralizing Antibodies in Chile after a Vaccination Campaign with Five Different Schemes
(2022)
Using levels of neutralizing antibodies (nAbs), we evaluate the successful Chilean SARS-CoV-2 vaccine campaign, which combines different vaccine technologies and heterologous boosters.
From a population-based study performed ...
Avaliação de um imunoensaio ELISA (enzyme-linked immunosorbent assay) padronizado utilizando proteína recombinante de nucleocapsídeo(50-350) de SARS-CoV-2 como ferramenta de avaliação de resposta imune humoral em indivíduos vacinados com CoronaVac.
(Florianópolis, SC., 2022-07-08)
Introdução: A Covid-19 é a doença causada pelo vírus SARS-CoV-2 que foi identificado no
início do ano de 2020 como o responsável por um quadro de infecção respiratória grave que
primeiramente atingiu pessoas da cidade ...
Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children
(American Society for Microbiology, 2022-12)
Multiple vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been evaluated in clinical trials. However, trials addressing the immune response in the pediatric population are scarce. The ...
Effectiveness of CoronaVac in children 3-5 years of age during the SARS-CoV-2 Omicron outbreak in Chile
(NATURE PORTFOLIO, 2022)
The outbreak of the B.1.1.529 lineage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Omicron) has caused an unprecedented number of Coronavirus Disease 2019 (COVID-19) cases, including pediatric hospital ...